CN Patent

CN115175913B — 取代的双三环化合物及其药物组合物和用途

Assigned to Zhihe Shandong Pharmaceutical Factory Co ltd · Expires 2023-11-28 · 2y expired

What this patent protects

一种取代的双三环化合物及其药物组合和用途,所述取代的双三环化合物如式(I)所示;该化合物对病毒具有抑制作用,可用于抗流感病毒。

USPTO Abstract

一种取代的双三环化合物及其药物组合和用途,所述取代的双三环化合物如式(I)所示;该化合物对病毒具有抑制作用,可用于抗流感病毒。

Drugs covered by this patent

Patent Metadata

Patent number
CN115175913B
Jurisdiction
CN
Classification
Expires
2023-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Zhihe Shandong Pharmaceutical Factory Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.